Entia Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| 2012 | 369.27K | -1.26M | -342.33% |
|---|---|---|---|
| 2013 | 314.74K | -3.24M | -1032.42% |
| 2014 | 656.34K | -2.63M | -401.67% |
| 2015 | 346.91K | -2.40M | -694.51% |
| 2016 | 265.46K | -1.47M | -554.75% |
| 2019 | 0 | 0 | |
| 2020 | 0 | 0 | |
| 2021 | 0 | 0 | |
| 2022 | 0 | 0 |
ERGO Income Statement (2012 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 0 | 0 | 265.46K | 346.91K | 656.34K | 314.74K | 369.27K |
Cost of revenue | 0 | 0 | 0 | 0 | 91.49K | 131.00K | 245.47K | 131.12K | 107.46K |
Gross profit | 0 | 0 | 0 | 0 | 173.96K | 215.90K | 410.87K | 183.62K | 261.80K |
Operating exp. | |||||||||
Research and development | 0 | 0 | 0 | 0 | 37.75K | 73 | 24 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 90.14K | 127.12K | 125.72K | 171.13K | 39.77K |
Total operating expenses | 0 | 0 | 0 | 0 | 1.34M | 2.13M | 2.18M | 2.86M | 1.34M |
Operating income | 0 | 0 | 0 | 0 | -1.16M | -1.91M | -1.77M | -2.68M | -1.08M |
Other income (expenses), net | 0 | 0 | 0 | 0 | -228.40K | -344.09K | -525.65K | -423.26K | -183.46K |
Income before tax | 0 | 0 | 0 | 0 | -1.39M | -2.26M | -2.29M | -3.10M | -1.26M |
Income tax expense | 0 | 0 | 0 | 0 | 76.88K | 149.28K | 339.70K | 144.68K | 0 |
Net income | 0 | 0 | 0 | 0 | -1.47M | -2.40M | -2.63M | -3.24M | -1.26M |
Earnings per share | |||||||||
Basic EPS | 0 | 0 | 0 | 0 | -0.05 | -0.09 | -0.28 | -0.43 | -0.17 |
Diluted EPS | 0 | 0 | 0 | 0 | -0.05 | -0.09 | -0.28 | -0.43 | -0.17 |